Joseph Aslan

Cited by

	All	Since 2019
Citations	2820	1571
h-index	28	23
i10-index	46	40

360

180

270

200620072008200920102011201220132014201520162017201820192020202120222023202425 13 27 37 36 47 71 140 128 141 154 195 217 194 269 320 323 348 115

Public access

View all

59 articles

5 articles

available

not available

Based on funding mandates

Co-authors

Owen JT McCartyProfessor of Biomedical Engineering, Oregon Health & Science UniversityVerified email at ohsu.edu
Joseph ShatzelOregon Health & Science UniversityVerified email at ohsu.edu
Rachel A. RiggPhD student, Department of Biomedical Engineering, Oregon Health & Science UniversityVerified email at ohsu.edu
Cassandra P. LorenResearcher, Oregon Health & Science UniversityVerified email at ohsu.edu
Larry DavidProfessor of Biochemistry and Molecular Biology, Oregon Health & Science UniversityVerified email at ohsu.edu
Iván Parra IzquierdoSenior Scientist at Boehringer IngelheimVerified email at boehringer-ingelheim.com
Monica T HindsOregon Health & Science UniversityVerified email at ohsu.edu
Anh T. P. NgoChildren's Hospital of PhiladelphiaVerified email at chop.edu
asako itakuraOregon Health & Science UniversityVerified email at ohsu.edu
Alexander Robert MelroseSenior Research Assistant, Oregon Health & Science UniversityVerified email at ohsu.edu
Laura D HealyPostdoctoral Researcher, The Scripps Research Institute, Oregon Health & Science UniversityVerified email at scripps.edu
Andras GruberAronora, Inc.Verified email at aronorabio.com
Özgün BaburAssistant Professor at University of Massachusetts BostonVerified email at umb.edu
Emek DemirOHSUVerified email at ohsu.edu
Tony J. ZhengOregon Health & Science UniversityVerified email at ohsu.edu
Thomas SimmenUniversity of AlbertaVerified email at ualberta.ca
Jonathan ChernoffFox Chase Cancer CenterVerified email at fccc.edu
Annachiara MitrugnoPostdoctoral Fellow, Oregon Health and Science UniversityVerified email at ohsu.edu
Hari Hara Sudhan LakshmananOregon Health and Science UniversityVerified email at mix.wvu.edu
Garth TormoenRadiation Oncology at St. Mary’s Regional Medical CenterVerified email at primehealthcare.com

Joseph Aslan

Associate Professor, Knight Cardiovascular Institute, Oregon Health & Science University

Verified email at ohsu.edu - Homepage

Platelets Proteomics Cell Signaling Cell Biology Cardiovascular Disease


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
PACS-2 controls endoplasmic reticulum–mitochondria communication and Bid-mediated apoptosis T Simmen, JE Aslan, AD Blagoveshchenskaya, L Thomas, L Wan, ... The EMBO journal 24 (4), 717-729, 2005	603	2005
Rho GTPases in platelet function JE Aslan, OJT McCarty Journal of Thrombosis and Haemostasis 11 (1), 35-46, 2013	229	2013
A physical sciences network characterization of non-tumorigenic and metastatic cells Scientific reports 3 (1), 1449, 2013	170	2013
S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation JE Aslan, GW Tormoen, CP Loren, J Pang, OJT McCarty Blood 118 (11), 3129-3136, 2011	135	2011
Platelet shape change and spreading. JE Aslan, A Itakura, JM Gertz, OJ McCarty Methods in molecular biology (Clifton, NJ) 788, 91, 2012	111	2012
Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function RA Rigg, JE Aslan, LD Healy, M Wallisch, MLD Thierheimer, CP Loren, ... American Journal of Physiology-Cell Physiology 310 (5), C373-C380, 2016	81	2016
Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis JE Aslan, H You, DM Williamson, J Endig, RT Youker, L Thomas, H Shu, ... Molecular cell 34 (4), 497-509, 2009	77	2009
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear CP Loren, JE Aslan, RA Rigg, MS Nowak, LD Healy, A Gruber, BJ Druker, ... Thrombosis research 135 (1), 155-160, 2015	76	2015
Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs Ö Babur, AR Melrose, JM Cunliffe, J Klimek, J Pang, ALI Sepp, ... Blood, The Journal of the American Society of Hematology 136 (20), 2346-2358, 2020	67	2020
Death by committee: organellar trafficking and communication in apoptosis JE Aslan, G Thomas Traffic 10 (10), 1390-1404, 2009	64	2009
The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation JE Aslan, SM Baker, CP Loren, KM Haley, A Itakura, J Pang, ... American Journal of Physiology-Cell Physiology 305 (5), C519-C528, 2013	62	2013
Causal interactions from proteomic profiles: Molecular data meet pathway knowledge Ö Babur, A Luna, A Korkut, F Durupinar, MC Siper, U Dogrusoz, ... Patterns 2 (6), 2021	59	2021
p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophils A Itakura, JE Aslan, BT Kusanto, KG Phillips, JE Porter, PK Newton, X Nan, ... Plos one 8 (9), e73063, 2013	59	2013
Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization RE Kosoff, JE Aslan, JC Kostyak, E Dulaimi, HY Chow, TY Prudnikova, ... Blood, The Journal of the American Society of Hematology 125 (19), 2995-3005, 2015	51	2015
P21 activated kinase signaling coordinates glycoprotein receptor VI–mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear JE Aslan, A Itakura, KM Haley, GW Tormoen, CP Loren, SM Baker, J Pang, ... Arteriosclerosis, thrombosis, and vascular biology 33 (7), 1544-1551, 2013	51	2013
Caught in the act–protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease G Thomas, JE Aslan, L Thomas, P Shinde, U Shinde, T Simmen Journal of Cell Science 130 (11), 1865-1876, 2017	49	2017
Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation JE Aslan, KG Phillips, LD Healy, A Itakura, J Pang, OJT McCarty American Journal of Physiology-Cell Physiology 305 (12), C1230-C1239, 2013	47	2013
Platelet proteomes, pathways, and phenotypes as informants of vascular wellness and disease JE Aslan Arteriosclerosis, thrombosis, and vascular biology 41 (3), 999-1011, 2021	40	2021
The contact activation system as a potential therapeutic target in patients with COVID‐19 JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, ... Research and practice in thrombosis and haemostasis 4 (4), 500-505, 2020	39	2020
Platelet Rho GTPase regulation in physiology and disease JE Aslan Platelets 30 (1), 17-22, 2019	37	2019

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors